173 related articles for article (PubMed ID: 31176519)
1. TSC2/PKD1 contiguous gene syndrome, with emphasis on a case with an atypical mild polycystic kidney phenotype and a novel genetic variant.
Reyna-Fabián ME; Alcántara-Ortigoza MA; Hernández-Martínez NL; Berumen J; Jiménez-García R; Gómez-Garza G; González-Del Angel A
Nefrologia (Engl Ed); 2020; 40(1):91-98. PubMed ID: 31176519
[TBL] [Abstract][Full Text] [Related]
2. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome.
Gupta S; Lohse CM; Rowsey R; McCarthy MR; Shen W; Herrera-Hernandez L; Boorjian SA; Houston Thompson R; Jimenez RE; Leibovich BC; Cheville JC
Eur Urol; 2022 Mar; 81(3):229-233. PubMed ID: 34876325
[TBL] [Abstract][Full Text] [Related]
3. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and genotype-phenotype correlation in patients with PKD1/TSC2 contiguous gene deletion syndrome.
Shang S; Mei Y; Wang T; Zheng X; Chen K; Xiong S; Dong Y; Chang Y; Wu X; Kong X; Tan M; Wu L; Zhang Y; Xiao Y; Xie Y; Cai G; Chen X; Li Q
Clin Nephrol; 2022 Jun; 97(6):328-338. PubMed ID: 35142283
[TBL] [Abstract][Full Text] [Related]
5. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.
Sampson JR; Maheshwar MM; Aspinwall R; Thompson P; Cheadle JP; Ravine D; Roy S; Haan E; Bernstein J; Harris PC
Am J Hum Genet; 1997 Oct; 61(4):843-51. PubMed ID: 9382094
[TBL] [Abstract][Full Text] [Related]
6. Infantile spasms and early-onset progressive polycystic renal lesions associated with TSC2/PKD1 contiguous gene deletion syndrome.
Matsubara Y; Akamine S; Chong PF; Kawakami S; Maehara K; Kaku Y; Kurokawa M; Morisada N; Iijima K; Kira R
Seizure; 2021 Mar; 86():82-84. PubMed ID: 33581549
[No Abstract] [Full Text] [Related]
7. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
[TBL] [Abstract][Full Text] [Related]
8. PKD1/TSC2 contiguous gene deletion syndrome.
Sundaram M; Kookana A; Duncan H; Mathew R
Nephrology (Carlton); 2017 Aug; 22(8):656-657. PubMed ID: 28685940
[No Abstract] [Full Text] [Related]
9. Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant.
Laass MW; Spiegel M; Jauch A; Hahn G; Rupprecht E; Vogelberg C; Bartsch O; Huebner A
Pediatr Nephrol; 2004 Jun; 19(6):602-8. PubMed ID: 15007723
[TBL] [Abstract][Full Text] [Related]
10. Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.
Ismail NF; Nik Abdul Malik NM; Mohseni J; Rani AM; Hayati F; Salmi AR; Narazah MY; Zabidi-Hussin ZA; Silawati AR; Keng WT; Ngu LH; Sasongko TH
Jpn J Clin Oncol; 2014 May; 44(5):506-11. PubMed ID: 24683199
[TBL] [Abstract][Full Text] [Related]
11. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
[TBL] [Abstract][Full Text] [Related]
12. Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy.
Furlano M; Barreiro Y; Martí T; Facundo C; Ruiz-García C; DaSilva I; Ayasreh N; Cabrera-López C; Ballarín J; Ars E; Torra R
Nefrologia; 2017; 37(1):87-92. PubMed ID: 27595512
[TBL] [Abstract][Full Text] [Related]
13. [TSC2/PKD1 contiguous gene deletion syndrome].
Llamas Velasco S; Camacho Salas A; Vidales Moreno C; Ceballos Rodríguez RM; Murcia García FJ; Simón de la Heras R
An Pediatr (Barc); 2013 Jul; 79(1):42-5. PubMed ID: 23402778
[TBL] [Abstract][Full Text] [Related]
14. TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.
Kacerovska D; Vrtel R; Michal M; Vanecek T; Vodicka R; Kreuzberg B; Ricarova R; Pizinger K; Danis D; Reischig T; Kazakov DV
Am J Dermatopathol; 2009 Aug; 31(6):532-41. PubMed ID: 19590422
[TBL] [Abstract][Full Text] [Related]
15. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.
Boehm D; Bacher J; Neumann HP
Am J Kidney Dis; 2007 Jan; 49(1):e11-21. PubMed ID: 17185137
[TBL] [Abstract][Full Text] [Related]
16. A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease.
Longa L; Scolari F; Brusco A; Carbonara C; Polidoro S; Valzorio B; Riegler P; Migone N; Maiorca R
Nephrol Dial Transplant; 1997 Sep; 12(9):1900-7. PubMed ID: 9306341
[TBL] [Abstract][Full Text] [Related]
17. Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies.
Torra R; Badenas C; Darnell A; Camacho JA; Aspinwall R; Harris PC; Estivill X
Am J Kidney Dis; 1998 Jun; 31(6):1038-43. PubMed ID: 9631851
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Reduced Expression of Contiguous
Meguro S; Koguchi T; Hakozaki Y; Onagi A; Matsuoka K; Hoshi S; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
Cancer Genomics Proteomics; 2023; 20(1):40-50. PubMed ID: 36581342
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Tuberous Sclerosis and Autosomal Dominant Polycystic Kidney Disease in the Era of Tolvaptan.
Guerra-Torres XE
Curr Rev Clin Exp Pharmacol; 2023; 18(3):284-290. PubMed ID: 35585803
[TBL] [Abstract][Full Text] [Related]
20. A case of TSC2-PKD1 contiguous deletion syndrome: Clinical features and effective treatment for epilepsy.
Pan X; Yang C; Ma S; Wang W; Liu P; Guo Y; Liu Y; Song J; Wu S; Yi L; Wei W; Chen Z
Int J Dev Neurosci; 2021 Apr; 81(2):191-199. PubMed ID: 33421197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
